Medpace Share Price

Medpace Share Price

NASDAQ: MEDP | Large Cap | Healthcare
$609.83
-$24.28 (-3.83%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • Similar Stocks
  • FAQs

Medpace Stock Performance

Open
$632.64
Prev. Close
$634.12
Circuit Range
N/A
Day Range
$607.50 - $632.64
Year Range
$375.00 - $693.69
Volume
12,342
Average Traded
$617.44

Medpace Share Price Today

As of 22 November 2026, Medpace Holdings, Inc.'s share price is $609.83. The stock opened at $632.64, compared to its previous close of $634.12. During today's trading session, Medpace Holdings, Inc.'s share price traded between $607.50 and $632.64, with an average price of $620.07. Over the past 52 weeks, the stock has recorded a high of $693.69 and a low of $375.00. In terms of performance, Medpace Holdings, Inc.'s share price has risen by 36.33% over the last six months and is up 2.65% on a year-on-year basis.

Medpace Share Price Chart

Line chart of the Medpace price trend over the selected period. The price fell overall, ranging from 607.50 to 632.64, ending at 609.83.
$607.50$632.64
L
Show Current Price
H

Medpace Stock Fundamentals & Key Indicators

Market Cap
$17.59B
PE Ratio (TTM)
32.98
Dividend Yield
0.00%
EPS (TTM)
$18.51
Revenue (TTM)
$2.53T
Return On Equity (TTM)
88.53%
Profit Margin
17.83%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
1.72%

Medpace Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$708.45$706.60$707.33$716.00
Net Profit$135.13$123.87$121.36$137.46
Net Profit Margin19.07%17.53%17.16%19.20%
Income ChangeN/A-8.33%-2.03%13.27%

Medpace Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1460.00$1885.84$2109.05$2530.23
Net Profit$245.37$282.81$404.39$451.12
Net Profit Margin16.81%15.00%19.17%17.83%
Income ChangeN/A15.26%42.99%11.56%

Medpace Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets985.851071.641063.01018.53
Current Assets989.621029.23593.83333.96
Total Assets1975.472100.871656.831352.5
Non Current Liabilities172.65170.77172.75162.64
Current Liabilities1343.751104.55925.13803.47
Total Liabilities1516.41275.321097.88966.11
Shareholders' Equity459.07825.55558.95386.39

Medpace Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating713.22608.82433.37388.05
Investing-31.14-28.31-34.63-38.74
Financing-860.39-154.01-182.64-775.78

About Medpace

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Medpace Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$644.75
$608.90
-6.62%
Oct 2026
$620.81
$652.04
+4.36%
Sep 2026
$593.95
$624.80
+2.18%
Aug 2026
$586.08
$611.45
+5.96%
Jul 2026
$534.87
$577.05
+8.99%
Jun 2026
$447.71
$529.44
+18.36%
May 2026
$421.33
$447.31
+6.77%
Apr 2026
$483.11
$418.94
-12.78%
Mar 2026
$443.33
$480.32
+6.32%
Feb 2026
$578.62
$451.76
-22.40%
Jan 2026
$558.88
$582.16
+3.68%
Dec 2025
$591.91
$561.48
-5.49%

Medpace Share Price FAQs